PHARMACEUTICALS: Medicare Slashes Drugs By Up To 60 Percent
But some drugs may actually get a payment bump.Any providers pining for Medicare payments for Part B drugs to stop plummeting could have a major shock in store.The Centers for Medicare and Medicaid Services issued the updated drug reimbursements that take effect April 1, 2005, and some drugs face sharp declines.
Carboplatin Payouts Down Drastically
For example, the payment for carboplatin (J9045) drops 39.6 percent, from $125.47 currently to $75.75 in the second quarter, according to an analysis released by the American Society of Clinical Oncology.Other drugs face steep payment declines as well...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: